300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Cryptocurrency
Film
Oil and Gas
Retail
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Social Network
Blockchain
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Music
Publishing
Mobile Apps
Art
Wine and Spirits
Manufacturing
Real Estate
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sporting Goods
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Brazil
LATAM
Puerto Rico
Oman
Poland
Cameroon
Guernsey
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
Ireland
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Europe
Qatar
Angola
Cyprus
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Bolivia
Estonia
Bahamas
Belize
Algeria
Italy
Hungary
Grenada
Belarus
Israel
Lithuania
Honduras
Iceland
Finland
Cambodia
Liechtenstein
Mongolia
Lebanon
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Benjamin Belldegrun, Founder & Managing Partner at Aliment Capital

Benjamin Belldegrun

Founder & Managing Partner @ Aliment Capital

London, United Kingdom

Benjamin Belldegrun is a Series B investor at Aliment Capital in London focused on Agriculture and Biotechnology. Benjamin Belldegrun is co-founder and managing partner at Pontifax AgTech.

Total investments:
14
Last investment:
Lead investor:
64%

Last updated:

Industries Benjamin Belldegrun invests in

AgricultureBiotechnologyAgTechFood and BeverageFruit

Stages Benjamin Belldegrun invests in

Series BSeries CSeries APrivate Equity

Countries Benjamin Belldegrun invests in

United StatesCanadaUnited Kingdom

Contacts

TypeContactValidation
Work email
Personal email
Work phone
Personal phone
Socials

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Agriculture 4 (29%)
  • Biotechnology 4 (29%)
  • AgTech 2 (14%)
  • Food and Beverage 2 (14%)
  • Fruit 1 (7%)
See all 11 industries →

Stage

  • Series B 4 (29%)
  • Series C 2 (14%)
  • Series A 1 (7%)
  • Private Equity 1 (7%)

Country

  • United States 4 (29%)
  • Canada 1 (7%)
  • United Kingdom 1 (7%)

Investments

CompanyDescriptionRoundLinks
At Tropic Biosciences, They develop high-performing commercial varieties of tropical crops which promote grower wellbeing, consumer health, and improved sustainable environmental practices, using cutting edge non-GMO gene editing techniques. $105M / Series C / Mar 12, 2026
Fruitist is one of the fastest-growing premium superfruit brands redefining healthy snacking.Formerly known as Agrovision, the company launched Fruitist as its flagship consumer brand and has since grown into a $1B+ global business. Known for its bold flavor, satisfying crunch, and consistent quality, Fruitist delivers craveable superfruits,including its top-performing Premium Jumbo Blueberries, across 12,500+ stores in 28 countries.Backed by top-tier investors including the Dalio Family Office and Aliment Capital, Fruitist operates a fully integrated, tech-enabled global supply chain designed to deliver fresh, premium fruit 52 weeks a year.Building on that momentum, Fruitist is expanding its portfolio to include blackberries, raspberries, and cherries with more varieties and snackable formats on the horizon.The company is driven by a singular mission: inspiring enjoyable and nutritious snacking. $100M / Private Equity / Aug 01, 2024
AnuAnuvia Plant Nutrients is an agricultural technology company developing a product to replace traditional fertilizer.The company manufactures high-efficiency, sustainable bio-based fertilizers for the agriculture, turf, and lawn care industries from recycled organic material, such as livestock waste, food waste, or other plant-based materials.Anuvia Plant Nutrients was founded in 2005 and is headquartered in Winter Garden, FL. $103M / Series C / Feb 23, 2021
Pairwise is a purpose-driven food+tech company dedicated to building a healthier world through better fruits and vegetables. Founded in 2017 by Drs. David Liu, Feng Zhang, J. Keith Joung, Tom Adams, and Haven Baker, Pairwise holds licenses from Harvard and Massachusetts General Hospital to base editing and high-fidelity enzymes, and has anexpanding internal portfolio of tools and traits. The Pairwise team is growing new types of fruits and vegetables, including leafy greens, berries, and stonefruit, with the first products expected within a few years. The Pairwise team is comprised of leaders in agriculture, CPG food, and research and development. $90M / Series B / Feb 03, 2021
At Tropic Biosciences, They develop high-performing commercial varieties of tropical crops which promote grower wellbeing, consumer health, and improved sustainable environmental practices, using cutting edge non-GMO gene editing techniques. $28.5M / Series B / Jun 04, 2020
At Tropic Biosciences, They develop high-performing commercial varieties of tropical crops which promote grower wellbeing, consumer health, and improved sustainable environmental practices, using cutting edge non-GMO gene editing techniques. $10M / Series A / Jun 13, 2018
Concentric develops ground-breaking agtech advancements that are safe for people, protect our natural resources and increase agriculture’s potential to feed the world. Concentric produces high-performance specialty biological products that naturally improve crop yields and replenish soils. $15.9M / Series B / Apr 20, 2018
Concentric develops ground-breaking agtech advancements that are safe for people, protect our natural resources and increase agriculture’s potential to feed the world. Concentric produces high-performance specialty biological products that naturally improve crop yields and replenish soils. $9.6M / Series B / Jan 03, 2018
Caribou Biosciences is a operator of a medical technology company intended to analyze cell and genome engineering. The company specializes in cellular engineering and analysis based on the CRISPR-Cas9 technology platform which paired with a guide RNA, cuts double-stranded DNA and allows for specific changes to DNA, enabling development oftherapeutics for agricultural biotechnology, industrial biotechnology and basic and applied biological research. $30M / Series B / May 16, 2016
Fruitist is one of the fastest-growing premium superfruit brands redefining healthy snacking.Formerly known as Agrovision, the company launched Fruitist as its flagship consumer brand and has since grown into a $1B+ global business. Known for its bold flavor, satisfying crunch, and consistent quality, Fruitist delivers craveable superfruits,including its top-performing Premium Jumbo Blueberries, across 12,500+ stores in 28 countries.Backed by top-tier investors including the Dalio Family Office and Aliment Capital, Fruitist operates a fully integrated, tech-enabled global supply chain designed to deliver fresh, premium fruit 52 weeks a year.Building on that momentum, Fruitist is expanding its portfolio to include blackberries, raspberries, and cherries with more varieties and snackable formats on the horizon.The company is driven by a singular mission: inspiring enjoyable and nutritious snacking. $150M / Private Equity
See all 14 investments →

Co-Investors

Aliment Capital

About Aliment Capital

VC Fund · Santa Monica, United States

Aliment Capital is a pioneering growth capital investor in food and agriculture technology. It makes global investments in growing businesses that boost agricultural productivity, nutrition, health, sustainability, and supply chain efficiency. The firm was founded in 2014 and is based in Santa Monica, California.

Aliment Capital Contacts

NameEmailPhoneSocials
Benjamin Belldegrun
Benjamin Belldegrun Founder & Managing Partner
Gil Demeter
Gil Demeter Investment Professional
Harry Savage
Harry Savage Vice President
Timothy Bluth
Timothy Bluth Principal
Tristan Berne
Tristan Berne Senior Associate

Sign up to unlock verified contacts

Unlock Contacts

See all 5 contacts →

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Cryptocurrency
Film
Oil and Gas
Retail
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Social Network
Blockchain
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Music
Publishing
Mobile Apps
Art
Wine and Spirits
Manufacturing
Real Estate
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sporting Goods
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Brazil
LATAM
Puerto Rico
Oman
Poland
Cameroon
Guernsey
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
Ireland
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Europe
Qatar
Angola
Cyprus
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Bolivia
Estonia
Bahamas
Belize
Algeria
Italy
Hungary
Grenada
Belarus
Israel
Lithuania
Honduras
Iceland
Finland
Cambodia
Liechtenstein
Mongolia
Lebanon
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Benjamin Belldegrun invest in?

Benjamin Belldegrun invests primarily in Agriculture, Biotechnology and AgTech startups, most often at Series B and Series C stage. Most of the 14 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Benjamin Belldegrun?

Public channels for Benjamin Belldegrun include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

When did Benjamin Belldegrun last invest?

The most recent investment recorded for Benjamin Belldegrun closed in Mar 2026. Shizune tracks 14 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Benjamin Belldegrun Benjamin Belldegrun Find email